10.800
−2,70%
2026-10-19
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -24.4% | -14.8% | 1 / 3 | +20.2% | -1.75 pp | -2.28 pp | +6.9% | 0.55 | 8.58 | 1.386 | +20,2% | 71,3 | −16,8% | 8.58 | 5.88 | +45,9% |
| Pts | 0 | 0 | 4 | 12 | 4 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 10.800 (close price on 2026-10-19)EPS (TTM): 1.259
Financial charts
1.Revenue & growth
VND bn1.386Q2/26
1.Revenue & growth
VND bn1.386Q2/26
2.Profit & growth
VND bn61,1Q2/26
3.Profit mix (Penman)
VND bn234Q2/26
4.Margins & cost structure
%16.0%Q2/26
5.Returns & cash cycle
% · days6.6%Q2/26
6.Earnings quality & cash
VND bn-125Q2/26
7.Asset structure
VND bn4.261Q2/26
8.Funding & debt health
VND bn · times4.261Q2/26
9.Revenue backlog
VND bn57,7Q2/26
10.Valuation
times · %8,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %510Q2/26
Adjusted EPS growth, latest quarter
-24.4%
Average adjusted EPS growth, 3 quarters
-14.8%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26